Ono Pharmaceutical Co., Ltd.
OPHLFOTCHealthcare● Active
$14.55
+$0.00(+0.00%)
Market Cap$6.8B
P/E Ratio—
52W High$18.67
52W Low$9.33
Ono Pharmaceutical Co., Ltd.（OPHLF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · OPHLF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $519.03B | $486.87B | $502.67B | $447.19B | $361.36B |
| Cost of Revenue | $142.61B | $147.95B | $127.13B | $110.06B | $93.51B |
| Gross Profit | $376.42B | $338.92B | $375.55B | $337.13B | $267.85B |
| Gross Margin %(computed) | 72.52% | 69.61% | 74.71% | 75.39% | 74.12% |
| Operating Expenses | |||||
| R&D Expenses | $147.97B | $149.87B | $112.38B | $95.34B | $75.88B |
| G&A Expenses | $0.00B | $91.57B | $73.37B | $68.81B | $62.62B |
| Total Operating Expenses | $272.44B | $279.17B | $212.44B | $184.83B | $152.94B |
| Operating Income | $103.99B | $59.75B | $163.10B | $152.29B | $114.91B |
| Operating Margin %(computed) | 20.03% | 12.27% | 32.45% | 34.06% | 31.80% |
| Interest Income | $3.98B | $4.77B | $4.03B | $2.48B | $2.71B |
| Interest Expense | $3.56B | $5.32B | $0.23B | $0.91B | $0.87B |
| Income Before Tax | $93.24B | $59.33B | $163.73B | $143.53B | $105.03B |
| Income Tax Expense | $22.89B | $9.16B | $35.69B | $30.62B | $24.34B |
| Net Income | $70.21B | $50.05B | $127.98B | $112.72B | $80.52B |
| Net Margin %(computed) | 13.53% | 10.28% | 25.46% | 25.21% | 22.28% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $150.19 | $106.55 | $266.61 | $230.85 | $162.19 |
| Wtd Avg Shares | 0.47B | 0.47B | 0.48B | 0.49B | 0.50B |
| EBITDA | $141.98B | $91.54B | $178.44B | $167.50B | $128.54B |
| EBITDA Margin %(computed) | 27.35% | 18.80% | 35.50% | 37.46% | 35.57% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · JPY · B
深入了解Ono Pharmaceutical Co., Ltd.
关于Ono Pharmaceutical Co., Ltd.（OPHLF）损益表
Ono Pharmaceutical Co., Ltd.（OPHLF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年，OPHLF实现营收$519.03B，毛利润$376.42B（毛利率72.52%），净利润$70.21B（净利率13.53%）。
常见问题
OPHLF · 4 问Ono Pharmaceutical Co., Ltd.（OPHLF）2026财年营收为$519.03B，同比up6.6%。
OPHLF revenueOPHLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09